pemetrexed,carboplatin,paclitaxel,vinorelbine,nivolumab,cisplatin,docetaxel,gemcitabine,ipilimumab,pembrolizumab
merck,bms
[]
 it would be of interest to see os curves removing pts who never received io. we may be curing some patients with stage iv disease, so the question is whether we have a higher % of durable disease control in the early disease setting compared to advanced.
Medical oncologist with Colorado Permanente Medical Group. Opinions are my own. no financial conflicts of interest.